Recent Post
The VIVA! Communications Method – Part 1
Theme: The anatomy of an effective disease awareness campaign Most disease awareness campaigns don’t change behaviour – The VIVA! Communications Method does Most disease awareness campaigns fail to change behaviour. Despite significant investment, patients still delay seeking care, conditions remain under-diagnosed, and stigma quietly persists. Awareness alone isn’t the problem. The challenge is how it’s…
Read MoreBeyond the seizure: rethinking epilepsy care from crisis response to risk prevention
For most chronic diseases, prevention is central to the conversation. In epilepsy, however, the system still largely reacts. Across Australia, an estimated 266,000 people are living with epilepsy, yet public understanding of the disease often begins and ends with the visible seizure. In many cases, care pathways still form around acut e events –…
Read More1 billion seniors by 2050: driving innovation in Pharma, Medtech & Biotech across APAC
Asia-Pacific (APAC) is on the cusp of an unprecedented demographic shift. Currently, an estimated 503 million people aged 65 or over – around 60% of the world’s older population – live in the region. By 2050, that number is projected to approach one billion, presenting both enormous societal challenges and significant opportunities for healthcare innovation.…
Read MoreVisualising complex science for maximum impact
In healthcare communications, some of the most important messages are decided before a single word is read. Scientific evidence, regulatory nuance, and patient impact demand careful explanation. Yet audiences scan, interpret, and react visually first. Visual communication acts as a shortcut to clarity, allowing complex ideas to be understood quickly and intuitively. Unlike written language,…
Read MoreRare but rarely recognised: Accelerating diagnosis, access, & innovation for rare diseases in Australia & APAC
Two million Australians are living with a rare disease, yet diagnosis can take five-to-seven years. Across APAC, fragmented systems, limited awareness, and uneven access to therapies create both challenges and opportunities for pharma, biotech, and medtech innovators. This Rare Disease Day, it’s time to move from awareness to action, shortening diagnostic journeys, improving access, and…
Read More